Filings

Form TypeForm DescriptionFiling DateReport DateView Report
4Statement of changes in beneficial ownership of securities9/29/20219/28/2021
8-KCurrent report9/24/20219/24/2021
10-KAnnual report [Section 13 and 15(d), not S-K Item 405]9/24/20216/30/2021
8-KCurrent report9/20/20219/17/2021
8-KCurrent report9/13/20219/10/2021
8-KCurrent report9/10/20219/9/2021
8-KCurrent report9/8/20219/7/2021
8-KCurrent report8/12/20218/12/2021
EFFECTNotice of Effectiveness7/22/2021
424B3Prospectus [Rule 424(b)(3)]7/22/2021
CORRESPCorrespondence7/19/2021
CORRESPCorrespondence7/19/2021
UPLOADSEC-generated letter7/19/2021
DNotice of Exempt Offering of Securities7/19/2021
S-1General form for registration of securities under the Securities Act of 19337/13/2021
8-KCurrent report7/2/20217/2/2021
8-KCurrent report6/30/20216/28/2021
8-KCurrent report6/29/20216/29/2021
8-KCurrent report6/23/20216/22/2021
8-KCurrent report6/17/20216/17/2021
8-KCurrent report6/9/20216/9/2021
8-KCurrent report5/13/20215/13/2021
10-QQuarterly report [Sections 13 or 15(d)]5/13/20213/31/2021
8-KCurrent report5/6/20215/6/2021
8-KCurrent report5/4/20215/4/2021
8-KCurrent report4/28/20214/28/2021
8-KCurrent report4/28/20214/28/2021
8-KCurrent report4/27/20214/27/2021
424B3Prospectus [Rule 424(b)(3)]3/16/2021
EFFECTNotice of Effectiveness3/15/2021

Investor Alerts

Sign up for investor alerts!
Sign Up

Information Request

Send us a request for information
Learn More

#1455 – 885 West Georgia St.
Vancouver, BC, Canada
V6C 3E8

Pharmaceutical

MANUFACTURING

Investor

CORPORATE

Learn

© Copyright 2024 InMed Pharmaceuticals Inc.

Subscribe

Sign up to receive emails from InMed Pharmaceuticals

"*" indicates required fields

Name*
Consent*